Medcotec raises £2.4M seed for single-use powder transfer tech
What's the deal? MedcotecDealroom has a profile for this one. Try Dealroom →, a Daresbury, UK-based maker of single-use powder transfer valve technology for pharmaceutical and industrial manufacturing, has raised more than £2.4 million in seed funding. Backers include NPIF II – Mercia Equity Finance (managed by Mercia VenturesDealroom has a profile for this one. Try Dealroom →), LYVA LabsDealroom has a profile for this one. Try Dealroom →, and the Liverpool City Region Seed FundDealroom has a profile for this one. Try Dealroom → (managed by AXM Venture CapitalDealroom has a profile for this one. Try Dealroom →), alongside private investors.
What's the endgame? Led by Emerson Mulvaney and Mike Taitt, Medcotec builds valve technology designed to improve safety, eliminate contamination risks, and cut costs for manufacturers handling powders. Its platform centres on the Helyx valve — a single-use, full-bore valve engineered to prevent powder blockages and sustain high pressure during production runs without expensive cleaning.
What's the money for? The company plans to use the funds to expand trials, grow its team, and commercialise the technology. It already works with a pharmaceutical company and other manufacturers that use powder systems.
The signal: At over £2.4 million, the raise lands in roughly the top quarter of seed rounds by size, a sign of investor confidence in niche manufacturing hardware aimed at a clear industrial pain point.
Read more: finsmes.com
Image credit: Generated with Gemini
